Use of nibp polypeptides
AssigneeTemple University of the Commonwealth of Higher Education Office of Technology Transfer
InventorWenhui Hu
Life of this patent
Estimating the term…
Abstract
Methods for regulating NF-κB activation in cells comprising introducing into the cell a vector comprising a nucleic acid sequence encoding a NIK and IKK2 Binding Protein (NIBP) polypeptide, wherein the NIBP polypeptide is expressed in the cell, are provided. Also provided are methods for reversing the cancerous phenotype of a cancer cell and for modulating neuronal differentiation.
Claims11
A method for inhibiting NF-κB activation in a cell, comprising introducing into the cell a vector comprising a nucleic acid sequence encoding a NIK and IKK2 Binding Protein (NIBP) polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 3 and 5-7, wherein the NIBP polypeptide is expressed in the cell.
A method for reversing the cancerous phenotype of a cancer cell, comprising introducing into the cell a vector comprising a nucleic acid sequence encoding a NIK and IKK2 Binding Protein (NIBP) polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 3-7 and 13-16, wherein the NIBP polypeptide is expressed in the cell.
A method for modulating neuronal differentiation of a cell, comprising introducing into the cell a vector comprising a nucleic acid sequence encoding a NIK and IKK2 Binding Protein (NIBP) polypeptide, wherein the NIBP polypeptide is expressed in the cell, and the cell is selected from the group consisting of a neural stem cell (NSC), a neural progenitor cell (NPC), and a cell having disrupted NIBP expression.
A host cell comprising a vector comprising a nucleic acid sequence encoding a NIK and IKK2 Binding Protein (NIBP) polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 1-7 and 13-16, wherein the cell is capable of expressing the NIBP polypeptide.
Dependencies are inferred from the claim text.